Ikeda, Shota
Shinohara, Keisuke
Tagawa, Koshiro
Tohyama, Takeshi
Kishimoto, Junji
Kazurayama, Masaya
Tanaka, Shinji
Yamaizumi, Masamitsu
Nagayoshi, Hirokazu
Toyama, Kensuke
Matsushima, Shouji
Tsutsui, Hiroyuki
Kinugawa, Shintaro
Article History
Received: 21 October 2023
Accepted: 30 December 2023
First Online: 3 January 2024
Competing interests
: KS reports grants from Daiichi Sankyo, Nippon Boehringer Ingelheim, and Otsuka Medical Devices. HT reports grants and/or personal fees from Daiichi Sankyo, Novartis Pharma, Otsuka Pharmaceutical, Pfizer Japan, Mitsubishi Tanabe Pharma, Teijin Pharma, Nippon Boehringer Ingelheim, AstraZeneca, Ono Pharmaceutical, Kowa, IQVIA Service Japan, MEDINET, Medical Innovation Kyushu, Bayer Yakuhin, Johnson & Johnson, NEC, Nippon Rinsho and Japanese Heart Failure Society. The other authors report no conflicts of interest.